The 2026 Measles Surge: A Working Parent’s Back-to-School Checklist
The 2026 Measles Surge: A Working Parent's Back-to-School Checklist
Updated September 27, 2026. Every figure below was read on that date from the CDC, its MMWR reports, state health departments, peer-reviewed cost studies and the BLS, all listed at the end. Cost figures are labelled with the year of dollars they are stated in, because they span 2011 to 2019 and are not interchangeable. No insurer or retailer prices appear. This is a summary of published data, not medical advice.
Is "surge" the right word? The counts say yes
CDC's published figures, as of September 24, 2026: 3,659 confirmed cases this year across 47 jurisdictions, 40 new outbreaks, with 95% of cases outbreak-associated and one death recorded. Against the two prior full years — 2,289 cases in 2025 and 285 in 2024 — the year to date is already 1.6 times all of 2025 and 12.8 times all of 2024. Those ratios are my arithmetic on CDC's counts, and CDC notes the 2025 and 2026 figures are preliminary.
The most recent year with a complete published breakdown is 2024, and it is the one to read for what a case looks like: 89% of cases were in people unvaccinated or of unknown status, 42% were children under 5, and 40% were hospitalised — 52% among the under-fives. CDC states two MMR doses are 97% effective and one is 93%. The equivalent breakdown for 2026 is not something this article can give you: CDC publishes those tables in a way that does not render to an ordinary fetch, so the 2026 hospitalisation and vaccination-status split is not stated here rather than being guessed.
On elimination status, one correction worth making because it circulates wrongly. No CDC or HHS statement says the United States has lost measles elimination. What exists is from PAHO, an intergovernmental body: the Americas lost regional measles-free status in November 2025 when endemic transmission was documented in Canada, and the United States determination sits with a regional commission meeting in November 2026.
The comparison that matters: two doses against one containment episode
Here is the whole decision in one table. Column A is prevention, priced from CDC's own vaccine price list dated June 18, 2026. Columns B and C are what a single episode costs a household, from federal wage data and from published outbreak studies.
| Option | Published figure | Dollar year | Multiple of A |
|---|---|---|---|
| A. Two MMR doses, private sector | 97.99 per dose, so 195.98 for the schedule | 2026 | 1x |
| A-minus. Two doses at the CDC contract price | 26.927 per dose, so 53.85 | 2026 | 0.27x |
| A-zero. Two doses under Vaccines for Children | no cost for the vaccine; an administration fee may apply | 2026 | — |
| B. One parent, 21 days of quarantine, unpaid | about 3,753 (15 workdays at 250.20 a day) | 2026 | 19.1x |
| B-alt. Productivity loss per quarantined person, as measured | 1,114 over 21 days, about 53 a day | 2019 Q1 | 5.7x |
| C. One hospitalisation | 14,456 per hospitalisation | 2018 | 73.8x |
| D. Total societal cost per case, Clark County study | 47,479 | 2019 Q1 | 242x |
Row B is built from BLS: median usual weekly earnings for full-time workers were 1,251 dollars in the second quarter of 2026, which is 250.20 dollars a workday across a five-day week, and a 21-day quarantine spans about 15 workdays. That division is mine. Row B-alt is not an estimate at all — it is the Clark County, Washington study's measured figure: 934,948 dollars of productivity loss borne by 839 quarantined people over a 21-day quarantine, which works out to 1,114 dollars each.
The two rows differ by a factor of three for a reason worth knowing: the study measured actual loss across a population that includes people with paid leave and people who are not earners, while row B prices the worst case for one earner with none. BLS reports that paid sick leave was available to 81% of private-industry workers as of March 2026 — so 19% of them are in row B rather than row B-alt.
Running it out five and ten years
Column A is a one-time cost in childhood; it does not recur, which is the point of it. What does escalate is the other side. For the twelve months to August 2026, CPI shows hospital services up 5.2% and hospital and related services up 5.5%, against medical care services at 2.5%, the aggregate medical care index at 1.6% and all items at 3.4%.
Note how misleading that 1.6% aggregate is: it is held down by medical commodities at minus 2.7% and health insurance at minus 8.5%. Projecting a hospital bill on 1.6% understates it badly. At the published 5.2% hospital-services rate, a 14,456-dollar hospitalisation becomes about 18,600 dollars in five years and 24,000 in ten. Those are multipliers of 1.29 and 1.66 applied by me to a figure stated in 2018 dollars — a scenario, not a forecast.
Put plainly: the prevention side of this ledger is a fixed two-figure or three-figure number that never inflates again, and the containment side is a four- or five-figure number growing at over 5% a year. There is no version of this arithmetic in which the order changes.
The time costs, which is what actually breaks a working week
| Clock | Published duration |
|---|---|
| Incubation, exposure to symptoms | 7 to 21 days; CDC average 11 to 12 days |
| Infectious period | 4 days before to 4 days after the rash appears |
| Isolation for a case | 4 days after rash onset |
| Quarantine, exposed and susceptible | 21 days; 28 days if immune globulin was given |
| School exclusion, unvaccinated exposed student (Texas guidance) | 21 days from last exposure, and it resets with each new exposure |
| How long a room stays infectious after the person leaves | up to 2 hours |
| Post-exposure vaccine window | within 72 hours |
| Post-exposure immune globulin window | within 6 days, at 0.5 mL/kg |
The line that makes this non-linear for a parent is the Texas reset rule. A 21-day exclusion that restarts every time there is a fresh exposure in the same school is not a 21-day problem; in a live outbreak it is an open-ended one. Nothing in the published cost studies prices that, because they measure completed episodes.
What a real exclusion looks like, from an MMWR report on a Lubbock child-care facility published June 4, 2026: of 287 enrolled children and 48 employees, 10 unvaccinated children with exemption forms were excluded, 5 were quarantined at home for 21 days, and 6 infants under 6 months — too young for even an early dose — were moved into a single classroom. MMR coverage among the children aged 12 months and over was 96%. Eight cases resulted anyway.
Why your own child's coverage is not the whole answer
CDC's school-year 2025–26 figures: national kindergarten MMR coverage 92.4%, down from 95.2% in 2019–20; any exemption 4.2%; exemptions rose in 41 states; 24 states report exemptions above 5%; and roughly 280,000 kindergartners lack documentation of completing the MMR series.
From CDC's own open data for that school year, 40 of the 51 reporting jurisdictions with an estimate are below 95%. The range runs from Idaho at 75.2% to West Virginia at 98.9%. Eleven jurisdictions are at or above 95%. The 95% figure is not a CDC-stated herd-immunity threshold in those words — it is the operational benchmark CDC uses in MMWR, and a 2026 peer-reviewed analysis states it as "measles requires vaccination coverage above 95% to prevent transmission".
The practical reading: your child's two doses protect your child at 97%. Whether your child's school closes for three weeks depends on the other 280,000.
The schedule, and the two exceptions worth knowing before a trip
Routine schedule: dose one at 12 to 15 months, dose two at 4 to 6 years, minimum interval between doses 28 days. MMRV's second dose comes 3 months after the first, up to age 12.
The exceptions are the part parents miss. The minimum age for an early dose is 6 months. Infants aged 6 to 11 months travelling internationally should have a dose before departure — and then still receive two more later, because the early dose does not count toward the two-dose schedule. Children 12 months and older travelling should have both doses, separated by at least 28 days, which means starting at least four weeks before you fly. In the West Texas outbreak, early doses were offered to infants aged 6 to 11 months in affected counties from April 7, 2025.
Tip: The published windows all turn on the date symptoms start, and the first one is fever rather than rash — which means the useful household record during a 21-day monitoring period is a dated temperature log. A digital thermometer and a note of the reading is what turns a vague week into a dated one. (These are Amazon Associate links — we may earn a small commission on qualifying purchases.)
What a hospitalisation actually involves
From MMWR's review of 54 hospitalised patients in the West Texas outbreak, published May 28, 2026: median length of stay 2 days, range 0 to 20; 90.7% were under 18; all 54 were unvaccinated or of unknown status, with none verified as vaccinated. Complications recorded: pneumonia 72.2%, hypoxia 68.5%, supplemental oxygen 70.4%, dehydration 46.3%, ICU admission 7.4%. The full outbreak, declared over on August 18, 2025, came to 762 cases, 99 hospitalisations and 2 deaths. CDC separately publishes a rate of 1 encephalitis case per 1,000 and 1 to 3 deaths per 1,000 children infected, and that up to 9 in 10 susceptible close contacts will develop measles.
Where the cost studies disagree, and by how much
These are not reconcilable, and pretending otherwise is how bad numbers spread.
- Cost per case spans a factor of twenty. New York City 2013: 6,801 (2013 dollars). A systematic review of 11 outbreaks: median 32,805, range 7,396 to 76,154 (2018 dollars). Clark County: 47,479 (2019 Q1 dollars). And a JAMA piece: responding to a single case "can be as high as 142,000" (2011 dollars). They measure different perspectives — public health, provider, societal — and different dollar years.
- Cost per contact traced. The review gives a median of 223 with a stated maximum of 746. Clark County reports 814 — above the review's own ceiling. Neither paper reconciles it.
- Incubation average. CDC's surveillance manual says 11 to 12 days; Washington State says 10 — but Washington measures exposure to fever while CDC's 14-day figure is exposure to rash.
- Hospitalisation rate depends entirely on the window chosen. The same West Texas outbreak reads as 18.5% over one reporting period, 18% over another, and 13.0% across the full outbreak.
Which way to err: use the lower case-cost figures when arguing about public budgets and the higher time figures when planning your own month. Being wrong about 21 days of childcare is expensive in a way that being wrong about 32,805 dollars of somebody else's containment budget is not.
What is not published
Four gaps. The 2026 and 2025 demographic and hospitalisation breakdowns exist on CDC's page but not in a form that can be read, so this article states 2024's instead. The Vaccines for Children administration-fee cap in dollars is set regionally by CMS from a fee schedule published in November 2012, and the amounts live on a non-public platform — so the one gap in the "A-zero" row above cannot be closed. There is no numbered CDC procedure for verifying a child's immunisation record, and the only published turnaround anywhere is Minnesota's registry at 14 business days. And nothing in any of this establishes that falling coverage caused the 2026 count; CDC publishes both trends on the same page and draws no causal link.
The checklist, in the order the numbers justify
- Confirm two documented doses, not "probably vaccinated". The distinction between 97% and 93% protection is one dose, and school exclusion turns on documentation rather than belief.
- Request the immunisation record now, not during an outbreak. Allow two weeks; Minnesota publishes 14 business days and most states publish nothing.
- Check your state's kindergarten coverage. Forty of 51 jurisdictions are below 95%, and that number decides your exposure, not your child's doses.
- If travelling, count back 28 days minimum — and for an infant 6 to 11 months, ask about an early dose knowing it does not replace the later two.
- Write down the 72-hour and 6-day post-exposure windows. They are short, and they are the only part of this you cannot get back.
- Find out today whether you have paid sick leave. Nineteen percent of private-industry workers do not, and 15 unpaid workdays is the single largest household number in this article.
The pattern here is the same one that shows up whenever a family cost is quoted as a headline rather than a measurement — worth reading alongside what a record back-to-school spending figure actually is, and how a small recurring household cost compounds over ten years.
Where each number came from
- CDC measles cases and outbreaks, as of September 24 2026: cdc.gov. Clinical overview and complication rates: cdc.gov. Surveillance manual chapter 7, isolation and quarantine: cdc.gov
- Vaccine recommendations, dose ages and post-exposure windows: cdc.gov. Health Advisory on early doses and travel, March 7 2025: cdc.gov
- CDC vaccine price list, June 18 2026: cdc.gov. Vaccines for Children eligibility and what families pay: cdc.gov
- Kindergarten coverage and exemptions, 2025–26: cdc.gov. Jurisdiction-level data: data.cdc.gov
- MMWR, hospitalised patients in the West Texas outbreak, May 28 2026: cdc.gov. Lubbock child-care facility, June 4 2026: cdc.gov
- Cost of outbreak response, systematic review (2018 dollars): pmc.ncbi.nlm.nih.gov. Clark County, Washington societal cost (2019 Q1 dollars): pmc.ncbi.nlm.nih.gov. New York City 2013: pmc.ncbi.nlm.nih.gov
- Washington State measles guideline, revised August 2026: doh.wa.gov. Texas school guidance, March 13 2025: dshs.texas.gov. Minnesota immunisation registry turnaround: health.state.mn.us
- BLS usual weekly earnings, second quarter 2026: bls.gov. Employee benefits, March 2026: bls.gov. CPI for August 2026: bls.gov
- Regional measles elimination status: paho.org
This article summarises published public-health data, peer-reviewed cost studies and federal statistics as of September 27, 2026. It is not medical advice and is not written by a clinician; no part of it is a recommendation about any individual child. Vaccination decisions, post-exposure treatment and school exclusion are matters for your clinician and your state or local health department, whose rules and effective dates differ from the ones cited here. Case counts are preliminary and change weekly.
Comments
Post a Comment